CRXT
Clarus Therapeutics Holdings, Inc.
Set alert
0.05 USD 0.00 0.00%
0.0475 Day range 0.0749
52-week range unavailable
- Open
- 0.065
- Prev close
- 0.0475
- Mkt cap
- 0
- Vol
- 2.74M
- Avg vol
- 0
- EPS
- -2.80
- P/E
- -0.02
- Div yield
- 0.00%
More statistics
- Low
- 0.0475
- High
- 0.0749
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 18, 2022
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 3.00
Valuation
P/E -1.0×
FY 2020 5y median -0.5× FY 2021
P/S 4.2×
FY 2020 5y median 2.1× FY 2021
P/B -3.7×
FY 2020 5y median 0.3× FY 2021
P/FCF -1.3×
FY 2020 5y median -0.7× FY 2021
EV/EBITDA -3.0×
FY 2020 5y median -3.3× FY 2021
EV/Sales 5.3×
FY 2020 5y median 2.7× FY 2021
FCF Yield -75.0%
FY 2020 5y median -37.5% FY 2021
Profitability
Gross Margin 80.5%
FY 2020 5y median 40.3% FY 2021
Operating Margin -177.1%
FY 2020 5y median -88.6% FY 2021
Net Margin -404.9%
FY 2020 5y median -202.5% FY 2021
ROE 355.0%
FY 2020 5y median 177.5% FY 2021
ROIC -88.6%
FY 2020 5y median -44.3% FY 2021
ROA -109.3%
FY 2020 5y median -54.6% FY 2021
Growth (YoY)
Revenue 0.0%
FY 2020 FY 2021
Operating Income 47.6%
FY 2020 FY 2021
EPS (diluted) 0.0%
FY 2020 FY 2021
Free Cash Flow 0.0%
FY 2020 FY 2021
Financial Health
Current Ratio 0.8×
FY 2020 5y median 1.4× FY 2021
Quick Ratio 0.6×
FY 2020 5y median 1.3× FY 2021
Debt / Equity -2.7×
FY 2020 5y median -1.3× FY 2021
Net Debt / EBITDA -0.6×
FY 2020 5y median -0.3× FY 2021
Interest Coverage -1.6×
FY 2020 5y median -0.8× FY 2021
Dividends
Dividend Yield 13.3%
FY 2020 5y median 6.6% FY 2021
Payout Ratio -13.7%
FY 2020 5y median -6.8% FY 2021
Annual · latest fiscal year ends 2021-12-31